Ewa Anna Kalinka (Ewa Kalinka)

Scopus Author ID Scopus Author ID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Epithelial Mesenchymal Transition

Endometrial Cancer

Prognostic Factors

Top Venues

International journal of molecular sciences

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tomasz Kucharczyk, Marcin Nicoś, Marek Kucharczyk, Ewa Anna Kalinka
NRG1 Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications. Cancers 16 (15) (2024)
Tomasz Kucharczyk, Marcin Nicoś, Marek Kucharczyk, Ewa Anna Kalinka
NRG1 Gene Fusions-What Promise Remains Behind These Rare Genetic Alterations? A Comprehensive Review of Biology, Diagnostic Approaches, and Clinical Implications. Cancers 16 (15) (2024)
Natalia Galant, Paweł Krawczyk, Marta Monist, Adrian Obara, Łukasz Gajek, Anna Grenda, Marcin Nicoś, Ewa Anna Kalinka, Janusz Milanowski
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection. International journal of molecular sciences 25 (11) (2024)
Natalia Galant, Paweł Krawczyk, Marta Monist, Adrian Obara, Łukasz Gajek, Anna Grenda, Marcin Nicoś, Ewa Anna Kalinka, Janusz Milanowski
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection. International journal of molecular sciences 25 (11) (2024)
Natalia Galant, Paweł Krawczyk, Marta Monist, Adrian Obara, Łukasz Gajek, Anna Grenda, Marcin Nicoś, Ewa Anna Kalinka, Janusz Milanowski
Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection. International journal of molecular sciences 25 (11) (2024)
Ewa Anna Kalinka, Kamila Wojas-Krawczyk, Paweł Krawczyk
Double Guard Efficiency and Safety-Overcoming Resistance to Immunotherapy by Blocking or Stimulating Several Immune Checkpoints in Non-Small Cell Lung Cancer Patients. Cancers 15 (13) (2023)
Tomasz Kucharczyk, Paweł Krawczyk, Dariusz Mirosław Kowalski, Adam Płużański, Tomasz Kubiatowski, Ewa Anna Kalinka
RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy. Cancers 14 (21) (2022)
Małgorzata Frąk, Anna Grenda, Paweł Krawczyk, Janusz Milanowski, Ewa Anna Kalinka
Interactions between Dietary Micronutrients, Composition of the Microbiome and Efficacy of Immunotherapy in Cancer Patients. Cancers 14 (22) (2022)
Miranda Gogishvili, Tamar Melkadze, Tamta Makharadze, Davit Giorgadze, Mikhail Dvorkin, Konstantin Penkov, Konstantin Laktionov, Gia Nemsadze, Marina Nechaeva, Irina Rozhkova, Ewa Anna Kalinka, Christian Gessner, Brizio Moreno-Jaime, Rodolfo Passalacqua, Siyu Li, Kristina McGuire, Manika Kaul, Anne Paccaly, Ruben G W Quek, Bo Gao, Frank Seebach, David M Weinreich, George D Yancopoulos, Israel Lowy, Giuseppe Gullo, Petra Rietschel
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial. Nature medicine 28 (11) (2022)
Małgorzata Frąk, Paweł Krawczyk, Ewa Anna Kalinka, Janusz Milanowski
Molecular and Clinical Premises for the Combination Therapy Consisting of Radiochemotherapy and Immunotherapy in Non-Small Cell Lung Cancer Patients. Cancers 13 (6) (2021)
Adi Diab, Scott S Tykodi, Gregory A Daniels, Michele Maio, Brendan D Curti, Karl D Lewis, Sekwon Jang, Ewa Anna Kalinka, Igor Puzanov, Alexander I Spira, Daniel C Cho, Shanhong Guan, Erika G Puente, Tuan Nguyen, Ute Hoch, Sue L Currie, Wei Lin, Mary A Tagliaferri, Jonathan Zalevsky, Mario Sznol, Michael E Hurwitz
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Laurent Mortier, Piotr Rutkowski, Jessica C Hassel, Catriona M McNeil, Ewa Anna Kalinka, Celeste Lebbè, Julie Charles, Micaela M Hernberg, Kerry Joane Savage, Vanna Chiarion Sileni, Catalin Mihalcioiu, Cornelia Mauch, Ana Arance, Francesco Cognetti, Lars Ny, Henrik Schmidt, Dirk Schadendorf, Helen J Gogas, Jesús Zoco, Sandra Re, Paolo Antonio Ascierto, Victoria Atkinson
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (33) (2020)
Kamila Wojas-Krawczyk, Ewa Anna Kalinka, Anna Grenda, Paweł Krawczyk, Janusz Milanowski
Beyond PD-L1 Markers for Lung Cancer Immunotherapy. International journal of molecular sciences 20 (8) (2019)